The group Radiation-Immunobiology was able to publish analyses showing that expression of danger signals (HSP70 and HMGB1) by glioblastoma during relapse situation has an beneficial effect on patient survival after Radio-Chemo-Therapy of the recurrent tumour.

The complete results can be found on pubmed.

For further questions please contact Prof. Udo Gaipl.